Kinetic Concepts, Inc. Release: Final Study Results Show V.A.C.® Therapy to be More Efficacious Than Advanced Moist Wound Therapy in Treating Diabetic Foot Ulcers

SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE:KCI) today announced the final efficacy results of a randomized controlled clinical trial (RCT) on the clinical efficacy of KCI’s V.A.C.® System negative pressure wound therapy (NPWT) compared to advanced moist wound therapy (AMWT) to treat diabetic patients with foot ulcers. The study, which showed that V.A.C. Therapy is more efficacious than AMWT in the treatment of diabetic foot ulcers, will be published in the April 2008 issue of Diabetes Care, the peer-reviewed journal of the American Diabetes Association. A pre-print version of the article is currently available online at http://diabetes.org/diabetescare.

MORE ON THIS TOPIC